RMTG (Regenerative Medical Technology Group) EBIT per Share : $0.00 (TTM As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Regenerative Medical Technology Group EBIT per Share?

Regenerative Medical Technology Group's EBIT per Share for the three months ended in Dec. 2024 was $0.03. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Regenerative Medical Technology Group's EBIT per Share or its related term are showing as below:

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Regenerative Medical Technology Group was 31.40% per year. The lowest was -140.60% per year. And the median was 12.45% per year.

RMTG's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 7.9
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Regenerative Medical Technology Group's EBIT for the three months ended in Dec. 2024 was $0.38 Mil.

Regenerative Medical Technology Group EBIT per Share Historical Data

The historical data trend for Regenerative Medical Technology Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenerative Medical Technology Group EBIT per Share Chart

Regenerative Medical Technology Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-0.18

-0.88

-0.10

-0.27

0.01

Regenerative Medical Technology Group Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT per Share	Get a 7-Day Free Trial															0.11	-0.01	-0.02	-	0.03

Regenerative Medical Technology Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Regenerative Medical Technology Group's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.079	/	12.532
=	0.01

Regenerative Medical Technology Group's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.382	/	12.539
=	0.03

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Regenerative Medical Technology Group (OTCPK:RMTG) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Regenerative Medical Technology Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of Regenerative Medical Technology Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerative Medical Technology Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenerative Medical Technology Group Inc (OTCPK:RMTG) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432

Website

https://www.regenmedtechgroup.com

Regenerative Medical Technology Group Inc operates through its subsidiary. Its focus has been mainly dedicated to its operations serving the markets in the regenerative medicine industry. It believes stem cell therapy is becoming an increasingly effective clinical solution for treating conditions that traditional or conventional medicine only offers within palliative care and pain management. Patients around the world are seeking a natural regenerative alternative without the potential risks and side effects sometimes associated with conventional pharmaceuticals.

Executives

Benito Novas	10 percent owner	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
David Eugene Christensen	director, 10 percent owner, officer: President and CEO	433 PLAZA REAL, SUITE 275, BOCA RATON FL 33432
Pereira Melvin Antonio Loria	director, 10 percent owner, officer: CEO, Chairman	RESIDENCIAL HACIENDA EL GREGAL, #24-1 SANCHEZ, CURRIDABAT, SAN JOSE G2 11803